Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 31,842 shares at $15.68 ($499K) on 2023-09-29, disclosed to the SEC on 2023-09-29.
Scheduled sale ($499k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.68 | 15,921 | $250K | 50.0% |
| 2 | $15.68 | 15,921 | $250K | 50.0% |
| Total | $15.68 avg | 31,842 | $499K | 100% |
| Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |
| CRSP | SELL | 2018-12-19 | $2.3M | — | Filing → |